Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07012135 · ClinicalTrials.gov registry record · NA

Deciphering Preserved Autonomic Function After Multiple Sclerosis

A NA study of Multiple Sclerosis and Autonomic Dysreflexia, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
13
Enrollment target
1
Study location

NCT07012135 is a NA study of Multiple Sclerosis and Autonomic Dysreflexia that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 13 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07012135, a NA study of Multiple Sclerosis and Autonomic Dysreflexia, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
13 participants
Enrollment target
1
Study location

Study Summary

This study looks to characterize gradients of dysfunction in the autonomic nervous system in patients with clinically diagnosed multiple sclerosis. The autonomic nervous system plays key roles in regulation of blood pressure, skin blood flow, and bladder health- all issues that individuals with multiple sclerosis typically suffer. Focusing on blood pressure regulation, the most precise metric with broad clinical applicability, the investigators will perform laboratory-based tests to probe the body's ability to generate autonomic responses. For both individuals with multiple sclerosis and uninjured controls, laboratory-based experiments will utilize multiple parallel recordings to identify how the autonomic nervous system is able to inhibit and activate signals. The investigators anticipate that those with autonomic dysfunction with multiple sclerosis will exhibit abnormalities in these precise metrics. The investigators will look to see if any substantial connections exist between different degrees of preserved autonomic function and secondary autonomic complications from multiple sclerosis. In accomplishing this, the investigators hope to give scientists important insights to how the autonomic nervous system works after multiple sclerosis and give physicians better tools to manage these secondary autonomic complications.

Interventions

  • DIAGNOSTIC_TEST Tests of sympathetic inhibition
  • DIAGNOSTIC_TEST Tests of sympathetic activation
  • DIAGNOSTIC_TEST Testing of autonomic dysreflexia

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2025-09-17
Est. Completion 2026-12-31
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT07012135

The ClinicalTrials.gov registry entry for NCT07012135 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (98% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Multiple Sclerosis appearing as the primary indexed condition, and to 3 interventions - of which Tests of sympathetic inhibition is the first listed.

NCT07012135 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT07012135 about?

NCT07012135 is a clinical study titled "Deciphering Preserved Autonomic Function After Multiple Sclerosis". This study looks to characterize gradients of dysfunction in the autonomic nervous system in patients with clinically diagnosed multiple sclerosis. The autonomic nervous system plays key roles in regulation of blood pressure, skin blood flow, and bladder health- all issues that individuals with mult...

What is the current status of trial NCT07012135?

This trial is currently recruiting. It is a NA study. The enrollment target is 13 participants. The study started on 2025-09-17. Estimated completion is 2026-12-31.

What conditions does trial NCT07012135 study?

This clinical trial studies the following conditions: Multiple Sclerosis, Autonomic Dysreflexia, Control Subjects.

What interventions are being tested in trial NCT07012135?

The interventions under investigation include: Tests of sympathetic inhibition (DIAGNOSTIC_TEST), Tests of sympathetic activation (DIAGNOSTIC_TEST), Testing of autonomic dysreflexia (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT07012135?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07012135 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.